Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.9K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

612
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
612
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.3K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk prediction for lung cancer screening: a systematic review and meta-regression.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study.

Thorax·2026
Same author

Prescription patterns of inhaler medications from 2017 to 2023: A retrospective study using Ontario administrative healthcare data.

PloS one·2026
Same author

Predicting 1-Year Stroke Recurrence and Mortality in Stable Outpatients Following Ischemic Stroke and Transient Ischemic Attack - ADDENDUM.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

The Effectiveness of Diabetes Prevention Programs Delivered in Primary Care for Individuals With Prediabetes or at Risk of Developing Type 2 Diabetes: A Systematic Review and Meta-analysis.

Diabetes care·2026
Same author

Preferences of pregnant individuals and family members for maternal-fetal health states related to anticoagulant use in pregnancy.

Thrombosis research·2026

Related Experiment Video

Updated: Dec 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study.

Elizabeth G Bond1, Lusine Abrahamyan2,3, Mohammad K A Khan4

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Plos One
|August 21, 2020
PubMed
Summary
This summary is machine-generated.

A new platform helps policymakers evaluate chronic obstructive pulmonary disease (COPD) interventions by identifying at-risk patient subgroups and assessing the impact of smoking cessation on healthcare resource use and survival.

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.4K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.5K

Related Experiment Videos

Last Updated: Dec 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.4K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.5K

Area of Science:

  • Health Economics
  • Clinical Epidemiology
  • Health Services Research

Background:

  • Chronic obstructive pulmonary disease (COPD) presents a substantial and varied burden on individuals and healthcare systems.
  • Policymakers require advanced tools to assess new interventions and target them effectively to specific patient populations.
  • Personalized tools are needed to evaluate interventions and stratify patients for optimal benefit.

Purpose of the Study:

  • To develop a platform for identifying high-risk COPD subgroups for emergency department visits, hospitalizations, and mortality.
  • To provide stratified patient input for economic evaluations of COPD interventions.
  • To quantify the impact of smoking cessation on resource utilization and survival in COPD patients.

Main Methods:

  • Utilized administrative and survey data from Ontario, Canada.
  • Employed a combination of microsimulation and multi-state modeling techniques.
  • Quantified outcomes across different smoking statuses (current, former, never smokers).

Main Results:

  • Cumulative incidence of all-cause mortality at 14 years varied by smoking status: 37.9% (never), 34.7% (current), and 46.4% (former).
  • Smokers who did not quit at diagnosis had 16.3% more COPD-related emergency department visits over 14 years compared to those who quit.
  • The platform demonstrated functionality in assessing risk and intervention effects.

Conclusions:

  • A novel tool combining clinical and economic modeling methods has been developed.
  • This platform can inform COPD policy decisions and quantify the effects of risk factor modification.
  • It aids policymakers and health economists in understanding resource utilization and mortality impacts.